Xphozah (tenapanor) — Medica

Initial criteria

• Patient is age ≥ 18 years
• Patient has chronic kidney disease (CKD)
• Patient has been on maintenance dialysis for ≥ 3 months
• Patient’s serum phosphate level is ≥ 5.5 mg/dL and < 10.0 mg/dL
• Patient meets ONE of the following:
• 1) Patient has tried at least two phosphate binders AND had an inadequate response and/or intolerance to at least two phosphate binders
• OR 2) Patient has a contraindication to at least two phosphate binders
• OR 3) Patient has inadequate response and/or intolerance to at least one phosphate binder AND a contraindication to at least one phosphate binder
• Prescribed by or in consultation with a nephrologist

Approval duration

1 year